We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+9.52%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.26B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
15.3%
Top 10 Hldgs %
36.86%
Holding
2,288
New
1,062
Increased
238
Reduced
222
Closed
745

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$22.9M
2
NFLX icon
Netflix
NFLX
+$14.7M
3
SNOW icon
Snowflake
SNOW
+$12.4M
4
LLY icon
Eli Lilly
LLY
+$8.58M
5
CRM icon
Salesforce
CRM
+$8.44M

Sector Composition

Rank Sector Weight
1 Communication Services 24.46%
2 Financials 17.08%
3 Technology 7.74%
4 Healthcare 6.69%
5 Consumer Discretionary 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHGA
1451
Change Agents Corporation Common Stock
CHGA
$2.83M
$6K ﹤0.01%
+814
New +$7.27K
BKKT.WS icon
1452
Bakkt Inc Warrants
BKKT.WS
$238K
$6K ﹤0.01%
+17,156
New +$3.35K
CPHI icon
1453
China Pharma Holdings
CPHI
$45.8M
$6K ﹤0.01%
934
-1,402
-60% -$7.87K
EDBL
1454
Edible Garden
EDBL
$1.14M
0
GXAI
1455
Gaxos.ai
GXAI
$9.51M
$6K ﹤0.01%
+1,454
New +$7.13K
MRIN
1456
DELISTED
Marin Software
MRIN
$6K ﹤0.01%
2,921
-87
-3% -$189
NCNA
1457
NuCana
NCNA
$5.99M
$6K ﹤0.01%
+4
New +$9.17K
RBOT
1458
DELISTED
Vicarious Surgical
RBOT
$6K ﹤0.01%
+508
New +$5.66K
SBFM
1459
Sunshine Biopharma
SBFM
$2.93M
$6K ﹤0.01%
+1
New +$5.69K
SINT icon
1460
SiNtx Technologies
SINT
$11.3M
$6K ﹤0.01%
+75
New +$7.29K
VGZ icon
1461
Vista Gold
VGZ
$331M
$6K ﹤0.01%
13,958
-21,714
-61% -$8.08K
XLO icon
1462
Xilio Therapeutics
XLO
$60.4M
$6K ﹤0.01%
+769
New +$15.2K
FMTO
1463
DELISTED
Femto Technologies Inc. Common Stock
FMTO
0
RNLX
1464
DELISTED
Renalytix plc American Depositary Shares
RNLX
$6K ﹤0.01%
+14,667
New +$11.7K
CMPOW
1465
DELISTED
CompoSecure Inc Warrant
CMPOW
$5K ﹤0.01%
+14,083
New +$7.17K
DXF
1466
Eason Technology Ltd
DXF
$1.72M
$5K ﹤0.01%
+96
New +$4.24K
GCTK icon
1467
GlucoTrack
GCTK
$2.87M
$5K ﹤0.01%
+3
New +$3.98K
GNLN icon
1468
Greenlane Holdings
GNLN
$1.24M
0
IVP
1469
DELISTED
Inspire Veterinary Partners
IVP
$5K ﹤0.01%
+6
New +$10.5K
KZIA
1470
Kazia Therapeutics
KZIA
$159M
$5K ﹤0.01%
229
-4
-2% -$117
SLDPW icon
1471
Solid Power Inc Warrant
SLDPW
$8.58M
$5K ﹤0.01%
24,432
+7,570
+45% +$1.47K
BRSH
1472
DELISTED
Bruush Oral Care Inc. Common Stock
BRSH
$5K ﹤0.01%
+42,115
New +$15.5K
HLTH
1473
DELISTED
Cue Health Inc. Common Stock
HLTH
$5K ﹤0.01%
+30,840
New +$10.2K
CRGE
1474
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$5K ﹤0.01%
42,128
+16,690
+66% +$4.53K
ARAV
1475
DELISTED
Aravive, Inc. Common Stock
ARAV
$5K ﹤0.01%
37,611
-52,465
-58% -$7.18K

Similar funds

Virtu Financial's Q4 2023 Portfolio in Review

As of Q4 2023, Virtu Financial held 2,288 positions worth $1.26B, up 26% from $1.01B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Virtu Financial deployed $193M of net new capital in Q4 2023, opening 1,062 new positions and adding to 238 existing holdings. Its largest new stake was State Street Technology Select Sector SPDR ETF: 304,340 shares worth $29.3M.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Microsoft, an estimated $22.9M trimmed.

  • Virtu Financial's largest Q4 2023 buy was State Street Technology Select Sector SPDR ETF: 304,340 shares worth $29.3M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q4 2023, an estimated $109M increase.
  • Virtu Financial's biggest Q4 2023 reduction was Microsoft, cutting an estimated $22.9M.
  • Virtu Financial fully exited Eli Lilly in Q4 2023, selling an estimated $8.58M.
  • Virtu Financial's ten largest holdings make up 37% of its $1.26B portfolio in Q4 2023.
  • Virtu Financial opened 1,062 new positions and closed 745 in Q4 2023.
  • Virtu Financial's portfolio value rose 26% quarter-over-quarter to $1.26B.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.